Impulsivity With Borderline Personality Disorder/tMS
This is a prospective, randomized, double-blind, parallel-group controlled trial. The aim of this research project is to compare the clinical benefits achieved in patients with Borderline Personality Disorder (BPD) following two types of intervention: ccPAS active or ccPAS sham.
| Condition(s) | Borderline Personality Disorder |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | This is a prospective, randomized, double-blind, parallel-group controlled trial. The aim of this research project is to compare the clinical benefits achieved in patients with Borderline Personality Disorder (BPD) following two types of intervention: ccPAS active or ccPAS sham. |
| Who can participate | Inclusion Criteria: * Diagnosis of BPD (established by a psychiatrist and confirmed in a structured interview using the MINI) based on the Diagnostic and Statistical Manual of Mental Disorders (DSM V). Exclusion Criteria: * Contraindications to TMS/MRI (pacemakers or other devices likely to interfere with the magnetic field). * Pregnant or breast-feeding women. * Ongoing anxiolytic treatment (benzodiazepines), neuroleptic treatment or anticonvulsants acting on GABAergic transmission ; 24 hours prior to the protocol. * Diagnosis of other chronic psychiatric pathology including bipolar disorder type I or II and addictions (except tobacco). * Protective measure (curatorship or guardianship) |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Hôpital le Vinatier |
| Locations | Bron, AURA, France |
| Start date | 2024-01-08 |
| NCT ID | NCT05942651 |
| Official listing | https://clinicaltrials.gov/study/NCT05942651 |